Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
TRIRF Triterras Inc
AIC Arlington Asset Investment Corp
LCID Lucid Group Inc
AMAT Applied Materials Inc
$DWCPAP DJTSM US Paper
CMMB Chemomab Therapeutics Ltd
DLTR Dollar Tree Inc
BAC Bank of America Corp
KW Kennedy-Wilson Holdings Inc
Go

Health Care : Biotechnology | Large Cap Value

AbbVie Inc. (AbbVie) is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta/Venclyxto; aesthetics products that include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products, which consists of Lumigan/Ganfort, Alphagan/Combigan and Restasis, and other key products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella and Synthroid. Its products are sold to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from the AbbVie-owned distribution centers and public warehouses.

Closing Price: $136.86

Day's Change: -0.01 (-0.01%)

Bid: --

Ask: --

B/A Size: --

Day's High: 138.31

Day's Low: 136.29

Volume (Light) Volume: 4,276,414 10-day average volume: 6,945,846: 4,276,414

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.